Rallybio (RLYB) Accumulated Depreciation (2020 - 2022)
Rallybio (RLYB) posted Accumulated Depreciation of $373000.0 for Q4 2022, up 81.07% sequentially from $206000.0 in Q4 2021, and up 81.07% YoY from $206000.0 in Q4 2021.
Rallybio (RLYB) Accumulated Depreciation (2020 - 2022) Analysis & Trends
Rallybio has reported Accumulated Depreciation for 3 years, with the latest figure at $373000.0 in Q4 2022.
- Quarterly Accumulated Depreciation rose 81.07% year-over-year to $373000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $373000.0 (up 81.07% YoY) and the FY2022 annual result came in at $373000.0, up 81.07% from the prior year.
- Accumulated Depreciation improved to $373000.0 in Q4 2022 per RLYB's latest filing, from $206000.0 in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $373000.0 in Q4 2022 and troughed at $97000.0 in Q4 2020.
- A 3-year average of $225333.3 and a median of $206000.0 in 2021 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2021 and 2022: Accumulated Depreciation soared 112.37% in 2021, then surged 81.07% in 2022.
- Over 3 years, Accumulated Depreciation stood at $97000.0 in 2020, then jumped by 112.37% to $206000.0 in 2021, then jumped by 81.07% to $373000.0 in 2022.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $373000.0, $206000.0, and $97000.0 for Q4 2022, Q4 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Rallybio | 94.61 Mn | 94.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 373,000.00 |
| Dec 31, 2021 | 206,000.00 |
| Dec 31, 2020 | 97,000.00 |